A Phase 1/2a Clinical Trial to Assess Safety of a Single IV Infusion of Autologous Adipose-derived Mesenchymal Stem Cells in Adults With Active Rheumatoid Arthritis
Latest Information Update: 04 Apr 2022
Price :
$35 *
At a glance
- Drugs Autologous adipose derived mesenchymal stem cells Hope Biosciences (Primary)
- Indications Rheumatoid arthritis
- Focus Adverse reactions
- Sponsors Hope Biosciences
- 08 Mar 2022 Results published in the Hope Biosciences Media Release
- 21 Oct 2020 Status changed from active, no longer recruiting to completed.
- 09 Jul 2020 Planned End Date changed from 1 Jun 2020 to 31 Jul 2020.